What are the treatment options for Multiple Myeloma

Q: What are the treatment options for Multiple Myeloma

According to the NCCN Guidelines for Patients: Multiple Myeloma, here are the main treatment approaches: Most people start with a combination of 3-4 medications, typically including: - A targeted therapy proteasome inhibitor or monoclonal antibody - An immunomodulator - A monoclonal antibody - A corticosteroid Proteasome Inhibitors block proteins that help myeloma cells survive: - Bortezomib Velcade - Carfilzomib Kyprolis - Ixazomib Ninlaro Monoclonal Antibodies attach to cancer cells and trigge

Multiple MyelomaAugust 13, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Treatment Options for Multiple Myeloma

According to the NCCN Guidelines for Patients: Multiple Myeloma, here are the main treatment approaches:

Multi-Drug Therapy (First-Line Treatment)

Most people start with a combination of 3-4 medications, typically including:

A targeted therapy (proteasome inhibitor or monoclonal antibody)
An immunomodulator
A monoclonal antibody
A corticosteroid

Targeted Therapy Medications

Proteasome Inhibitors (block proteins that help myeloma cells survive):

Bortezomib (Velcade)
Carfilzomib (Kyprolis)
Ixazomib (Ninlaro)

Monoclonal Antibodies (attach to cancer cells and trigger immune attack):

Daratumumab (Darzalex)
Elotuzumab (Empliciti)
Isatuximab (Sarclisa)

Immunomodulators (boost immune response):

Lenalidomide (Revlimid)
Pomalidomide (Pomalyst)
Thalidomide (Thalomid)

Bispecific Antibodies (connect T cells directly to myeloma cells):

Elranatamab (Elrexfio)
Linvoseltamab (Lynozyfic)
Talquetamab (Talvey)
Teclistamab (Tecvayli)

Other Targeted Options:

CAR T-cell therapy (Abecma, Carvykti)
Antibody-drug conjugates (Belantamab mafodotin)
Small molecule inhibitors (Venetoclax)
Nuclear export inhibitors (Selinexor)

After Initial Therapy

Hematopoietic cell (stem cell) transplant — not everyone receives this
Radiation therapy — for specific bone lesions
Surgery — in certain cases
Clinical trials — access to newer treatments

Supportive Care (Available with Any Treatment)

Medications to strengthen bones and reduce fractures (bisphosphonates, denosumab)
Management of side effects and symptoms
Emotional, spiritual, and financial support

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →